Adduct of Malondialdehyde to Hemoglobin : A New Marker of Oxidative Stress That Is Associated with Significant Morbidity in Preterm Infants

Abstract EN

Preterm infants (PT) are particularly exposed to oxidative stress (OS), and a blood-sparing marker, the malondialdehyde adduct to hemoglobin (MDA-Hb), may be useful to accurately assess OS-related neonatal morbidity.

In a prospective study, MDA-Hb concentrations were assessed in two groups of PT, one with and one without severe neonatal morbidity as estimated by a composite index of severe morbidity (ISM).

All PT born in a single tertiary care NICU (<32 weeks and birth weight <1500 g) were consecutively included.

MDA-Hb and blood glutathione (GSH) concentrations were measured by liquid chromatography-mass spectrometry during the first 6 weeks of life.

Linear regressions and a multilevel model were fitted to study the relationship between MDA-Hb or GSH and ISM.

Of the 83 PT (mean ± SD: 28.3±2 weeks, 1089±288 g), 21% presented severe neonatal morbidity.

In the multivariate model, MDA-Hb concentrations were significantly higher in the ISM+ group than in the ISM– group during the first 6 weeks of life (P=0.009).

No significant difference in GSH concentrations was observed between groups (P=0.180).

MDA-Hb is a marker of interest for estimating oxidative stress in PT and could be useful to evaluate the impact of strategies to improve perinatal outcomes.